This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by GALWAY, A. B. Articles by SNYDER, P. J. Search for Related Content PubMed PubMed Citation Articles by GALWAY, A. B. Articles by SNYDER, P. J.

Gonadotroph Adenomas in Men Produce Biologically Active Follicle-Stimulating Hormone^*

A. BRENDA GALWAY, AARON J. W. HSUEH, LEELA DANESHDOOST, MEI-HUA ZHOU, SPYROS N. PAVLOU and PETER J. SNYDER

Department of Reproductive Medicine M-025, University of California-San Diego (A.B.G., A.J. W.H., M.-H.Z.) La Jolla, California 92093;
University of Pennsylvania School of Medicine (L.D., P.J.S.) Philadelphia, Pennsylvania 19104;
the Department of Medicine, Vanderbilt University (S.N.P.) Nashville, Tennessee 37232

Gonadotroph adenomas may exhibit qualitative and quantitative defects in gonadotropin biosynthesis and secretion. Hypersecretion of immunoreactive FSH dimers by these adenomas occurs frequently; however, it has not been known whether this FSH is biologically active. Using the granulosa cell aromatase bioassay and a highly specific immunoradiometric assay for FSH, we studied the serum bioactivity and bio- to immunoactivity (B/I) ratios of 14 men with FSH-secreting adenomas and compared these values to those of 11 age-matched normal men. In addition, three adenoma patients received TRH (400 µg, iv). The mean basal serum FSH level (international units per L), as measured by both bio- and immunoassays, and the FSH B/I ratios were significantly higher (P < 0.02, by Kolmogorov-Smirnov test) in the adenoma patients than in normal men (mean ± SEM; adenoma patients: bioactivity, 68.8 ± 10.4; immunoreactivity, 34.8 ± 13.7; B/I ratio, 3.4 ± 0.6; normal men: bioactivity, 5.8 ± 1.2; immunoreactivity, 6.4 ± 0.8; B/I ratio, 0.90 ± 0.1). Both bio- and immunoactive FSH rose after TRH injection, resulting in maintenance of the B/I (mean ± SEM; pre-TRH: bio-FSH, 63.7 ± 22.4; immuno-FSH, 28.0 ± 14.1; B/I ratio, 2.8 ± 1.2; post-TRH: bio-FSH, 125.6 ± 42.7; immuno-FSH, 45.8 ± 21.8; B/I ratio, 3.5 ± 1.6). When gonadotroph adenoma cells from three separate patients were cultured and their conditioned media (n = 3) studied, relatively large amounts of both bio- and immuno-FSH were detected. Furthermore, the major isoelectric profile of bio-FSH (pH 4.9–3.0) in the conditioned medium from two such adenomas was shown by chromatofocusing to be comparable to that of purified human pituitary FSH (pH 5.2–3.6). We conclude that gonadotroph adenomas in men secrete FSH that is biologically active, both basally and in response to TRH.

^* This work was supported by NIH Grants HD-23273 (to A.J.W. HD-13869 (to P.J.S.), and RR-0040.

Recipient of a Canadian Medical Research Council Postdoctoral Fellowship.

Received February 5, 1990.

This article has been cited by other articles:

				T. Kajitani, S. Liu, T. Maruyama, H. Uchida, R. Sakurai, H. Masuda, T. Nagashima, M. Ono, T. Arase, and Y. Yoshimura Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report Hum. Reprod., February 1, 2008; 23(2): 435 - 439. [Abstract] [Full Text] [PDF]

				I. Shimon, T. Rubinek, I. Bar-Hava, D. Nass, M. Hadani, A. Amsterdam, and G. Harel Ovarian Hyperstimulation without Elevated Serum Estradiol Associated with Pure Follicle-Stimulating Hormone-Secreting Pituitary Adenoma J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3635 - 3640. [Abstract] [Full Text] [PDF]

				A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text]

				T. R. Kumar, G. Palapattu, P. Wang, T. K. Woodruff, I. Boime, M. C. Byrne, and M. M. Matzuk Transgenic Models to Study Gonadotropin Function: The Role of Follicle-Stimulating Hormone in Gonadal Growth and Tumorigenesis Mol. Endocrinol., June 1, 1999; 13(6): 851 - 865. [Abstract] [Full Text]

				L. Gnessi, A. Fabbri, and G. Spera Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment Endocr. Rev., August 1, 1997; 18(4): 541 - 609. [Abstract] [Full Text] [PDF]